Estimaciones de analistas de Wall Street para DarioHealth Corp. (DRIO): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 8 |
| Mantener | 1 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 9 |
| Calificación media (1-5) | 0.89 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.51 | ||
| 2026-08-11 | $-0.85 | $-1.22 | +30.3% |
| 2026-05-13 | $-0.81 | $-1.09 | +25.7% |
| 2026-03-19 | $-0.80 | $-2.44 | +67.2% |
| 2025-11-13 | $-1.85 | $-3.97 | +53.4% |
| 2025-08-12 | $-2.40 | $-2.20 | -9.1% |
| 2025-05-14 | $-1.20 | $-1.40 | +14.3% |
| 2025-03-10 | $-0.20 | $-0.24 | +16.7% |
Ratios de valoración
| Ratio P/E | 9.83 |
| Precio / Valor contable | 1.15 |
| EV / EBITDA | -2.65 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $2.8M | $5.2M | $7.4M | $7.6M | $7.6M | $20.5M | $27.7M | $20.4M | $27.0M | $22.4M |
| Coste de Ventas | $3.4M | $3.9M | $5.6M | $5.0M | $5.1M | $12.4M | $18.0M | $14.4M | $13.8M | $9.7M |
| Beneficio Bruto | -$561000 | $1.3M | $1.8M | $2.6M | $2.5M | $8.1M | $9.7M | $6.0M | $13.3M | $12.7M |
| I+D | $2.2M | $3.3M | $3.7M | $3.7M | $4.4M | $17.2M | $19.6M | $20.2M | $24.2M | $13.8M |
| Generales y Administrativos | $8.1M | $12.4M | $15.8M | $16.6M | $28.0M | $62.4M | $46.8M | $41.8M | $46.8M | $35.5M |
| Gastos Operativos | $10.3M | $15.7M | $19.5M | $20.3M | $32.4M | $84.6M | $66.5M | $62.2M | $71.0M | $49.3M |
| Beneficio Operativo | -$11.1M | -$14.4M | -$17.7M | -$17.7M | -$29.9M | -$76.5M | -$56.8M | -$56.2M | -$57.7M | -$36.7M |
| EBITDA | -$10.4M | -$14.2M | -$17.5M | -$17.5M | -$29.7M | -$70.0M | -$55.6M | -$54.4M | -$37.1M | -$34.7M |
| Gastos por Intereses | $20000 | $171000 | $18000 | $27000 | $49000 | $84000 | $2.7M | $645000 | $96000 | $3.4M |
| Beneficio Antes de Impuestos | -$10.9M | -$15.7M | -$17.8M | -$17.7M | -$29.4M | -$76.7M | -$62.2M | -$59.4M | -$44.6M | -$41.6M |
| Impuestos | $55000 | 0 | -$115000 | 0 | 0 | $32000 | $4000 | $64000 | -$1.9M | $105000 |
| Beneficio Neto | -$10.9M | -$15.7M | -$17.8M | -$17.7M | -$29.4M | -$76.8M | -$62.2M | -$59.4M | -$42.7M | -$41.7M |
| BPA | $-41.85 | $-32.70 | $-15.21 | $-7.84 | $-5.55 | $-4.63 | $-2.63 | $-1.93 | $-0.74 | $-0.81 |
| BPA Diluido | $-41.85 | $-32.70 | $-15.21 | $-7.84 | $-5.55 | $-4.63 | $-2.63 | $-1.93 | $-0.74 | $-0.81 |
| Acciones en Circulación (Diluidas) | $260148 | $481412 | $1.2M | $2.3M | $6.0M | $16.6M | $23.6M | $28.4M | $40.4M | $49.6M |
Precio
| Precio | $6.78 |
| Capitalización | $50M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ABSI · AVNS · FLGT · INNV · MYGN · NNNN · OFIX
Explorar sector: Healthcare · Medical - Specialties
Más secciones de DRIO: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones